Units

Units is a biotechnology company focused on developing the next generation of cell therapies by creating off-the-shelf, functional human cells. The company's platform utilizes advanced stem cell biology and engineering to produce high-quality, scalable cell products designed to treat chronic diseases. Their lead program is focused on developing insulin-producing beta cells for the treatment of Type 1 diabetes. By leveraging a proprietary manufacturing process, Units aims to overcome the limitations of current cell therapy approaches, such as donor scarcity and high production costs. The company is led by a team with significant experience in regenerative medicine and cell therapy development.